期刊文献+

临床路径在子宫肌瘤射频消融手术患者中的应用体会

Effect analysis of clinical pathway for hysteromyoma treated with radiofrequency ablation
原文传递
导出
摘要 目的探讨应用临床路径护理在射频消融术中治疗子宫肌瘤患者的效果。方法由临床路径发展小组采用临床路径表格式病例实施标准化、治疗和护理,选择直径≤5cm的子宫肌瘤,在B超定位下,用射频治疗仪专用穿刺针治疗。结果65例患者手术后分别为3个月、6个月复查B超显示:62例子宫肌瘤消失;3例子宫肌瘤缩小。结论射频消融术治疗子宫肌瘤具有不开刀、操作简单、痛苦小、并发症发生率低等优点,是一种安全可靠地治疗子宫肌瘤的新方法。 Objective To explore the therapeutic effect and nursing of 65 myomas of uterus treated with radiofrequeney ablation. Methods 65 patients with uterine myoma (diameter≤5 cm) were treated with radiofrequeney ablation under - ultrasound. Before operation, fullpreparation was performed, the sense, complexions and vital signs were observed during treatment, and after treatment, pains in belly, bleeding of vagina, fever were closely monitored to prevent infection. Results All the patients were successfully treated. Re - examinations 3 months and 6 months after operation were conducted by B - ultrasound: 62 myomas of uterus disappered. 3 shrank. 1 bleeding, Duringtreatment, bleeding stopped. There were no. injuries in organs in abdominal cavities and no infections in pelvic cavities. Conclusion The treatment of myomas of uterus with radiofrequeney ablation has the advantages of using no operating scalpel, safety, efectiveness, simplicity in operation less pains, less adverse reaction, lower rate of complications. As a new minimally invasive therapy for myomas of uterus, it is safe and effective.
出处 《国际护理学杂志》 2007年第11期1188-1189,共2页 international journal of nursing
关键词 临床路径 子宫肌瘤 射频消融 护理 Myomas of uterus Radiofequeney ablation Clinical pathway
  • 相关文献

参考文献4

二级参考文献35

  • 1[2]Hofmann PA.Critical path method:An important tool for coordinating clinical care. Journal on Quality Improvement, 1993,19(7):235-246.
  • 2[3]Thomas R,Gadacz MD. General surgical clinical pathways:an introduction.The American Surgeon,1997,63(1):107-110.
  • 3[4]Phei Langchang,Shih Tsunghuang,Ming Lihsieh,et al.Use of the transurethral prostatectomy clinical path to monitor health outcomes.The Journal of Urology,1997 ,157(1):177-183.
  • 4[6]Graybeal KB,Gheen M,Mckenna B,et al.Clinical pathway development:The overlake model.Nursing Management,1993,24(4):42-45.
  • 5[7]Zander K.Managed care and nursing case management in patient care delivery models.Edited by Mayer GG, Maddin MJ,Lawrenz Rockville E,et al . Aspen Publications,1990.38.
  • 6[10]Windle P.Critical pathways:An integrated documentation tool.Nursing Management,1994,25(9):80F-80P.
  • 7[11]Pearson SD,Goulart-Fisher D,Lee TH,et al. Critical pathways as a strategy for improving care:problems and potential.Annals of Internal Medicine,1995,123(12):941-948.
  • 8[12]Anders RL,Tomai JS,Clute RM ,et al.Development of a scientifically valid coordinated care path.Journal of Nursing America,1997,27(5):45-51.
  • 9[13]Quigley,Patricia A,Strugar, et al.Successful experiences with clinical pathways in rehabilitation. Journal of Rehabilitation,1998,64(2):29-36.
  • 10[14]Mosher C,Cronk P,Kidd A,et al.Upgrading practice with critical pathways.American Journal of Nursing,1992,92(1):41-44.

共引文献752

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部